CORONANSECORONA Remedies LimitedLowNeutral
Announced Tue, 12 May · 15:23 IST

CORONA Remedies Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

CORONA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.8%1-day move
₹1765.00
prior close
₹1632.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5-2.8+1.3-0.6+3.1+0.7-2.5-3.3-1.8+16.7
Up moveDown movePending
AI summary

CORONA Remedies Limited has disclosed the availability of the audio recording from its earnings conference call with analysts and investors. The call covered the audited financial results for Q4 and full year ended March 31, 2026. The recording is accessible on the company's website. This is a routine regulatory compliance filing under SEBI LODR Regulation 30, informing stakeholders where they can access the earnings call discussion. The actual financial results and any management commentary would be contained in the audio file rather than this disclosure letter.

Likely market impact

This filing is informational in nature and does not contain any new financial data or guidance. It simply provides access to the previously announced Q4 FY26 earnings discussion. Shareholders who wish to hear management's commentary on performance can access the recording directly from the company's website.